Interestingly, here we also found that SNHG17/miR-876-5p/ERLIN2 axis also contributed to the resistance of astrocytoma cells to temozolomide (TMZ), a routinely-used drug for treating patients with gliomas including astrocytoma [24]. Here, ERLIN2 is linked to astrocytoma (excluding glioblastoma).